When the drugs don’t work: How the UK became addicted to antidepressants May 14, 2024 Almost one in four adults are being prescribed antidepressants, but they are not as effective as was once believed, writes Lucy Kenningham
Long-term sickness now top reason for women being out of work May 13, 2024 Long-term sickness has become the main reason for women being out of work, according to research by one trade union.
Therapie Clinic rolls out trending polynucleotides skin treatment May 8, 2024 Therapie is one of the first aesthetic clinic groups in the UK to make the polynucleotides treatment widely accessible in multiple locations.
Long-term sickness: How worsening mental health is holding back the economy May 4, 2024 Economic inactivity, driven by long-term sickness, is fast becoming one of the most pressing challenges facing the UK economy.
Sales downturn at Spectris after sale of software firm May 2, 2024 Precision instrument maker Spectris experienced a slower first start to the year than expected, it announced in its quarterly update.
Haleon posts healthy first quarter update after UK job cuts May 1, 2024 Revenue at Haleon was up in the first quarter despite its announcement yesterday that it would cut over 400 jobs in the UK, as the consumer healthcare firm posted a quarterly update in line with expectations.
UK firms want tax incentives to invest in employee health amid growing sickness crisis April 30, 2024 The report comes amid a growing debate about the impact of long-term sickness on the UK labour force.
Astrazeneca: London-listed pharma giant heralds successful breast cancer drug April 29, 2024 Astrazeneca has found that Enhertu helped patients live longer without their breast cancer getting worse compared to standard chemotherapy.
One Health Group sees patients soar as NHS buckles with growing waiting lists April 29, 2024 One Health's services are easing the load on the nation's embattled health service which is buckling under the weight of long waiting lists.
Drugmaker Indivior seeks shareholder approval to move primary listing from London to New York April 25, 2024 Opioid dependence treatment maker Indivior has confirmed a plan to move its primary stock market listing from London to New York this summer in yet another blow to the capital's beleaguered bourse.